Centre bans 16 fixed-dose drug combinations citing public health concerns
The Centre has prohibited the manufacture, sale and distribution of 16 fixed-dose combination (FDC) drugs, saying they lack “therapeutic justification” and their continued use was not considered beneficial in relation to the potential risks involved. The Ministry banned the FDC in the notifications issued under Section 26A of the Drugs and Cosmetics Act, 1940. (Representational Photo/Unsplash) The move, the Union Health Ministry said, was to safeguard public health and promote rational use of medicines while ensuring only effective and scientifically validated medicines are available to the public. Also Read| Spl campaign against drugs to be launched across 441 panchayats in Shimla: Kashyap FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients (APIs) in a fixed ratio. The decision follows a review of FDCs undertaken in compliance with the Supreme Court’s directions. The Drugs Technical Advisory Board (DTAB) had constituted an expert committee to examine various drug combinations and identify those that were irrational, therapeutically unjustified or potentially harmful. “The manufacture for sale, sale, distribution and supply of the identified …

